Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Price:
21.45 USD
-0.19%
Updated:
May 6, 2024
Fusion Pharmaceuticals Inc
Cash from Investing Activities
|
Fusion Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Comparables:
ZYME
TH
RPTX
AUPH
EDT
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Investing Activities
$1.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
-$6.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-149%
|
CAGR 10-Years
-67%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-42.8m
USD
-42.8m
USD
Based on the financial report for Dec 31, 2023, Fusion Pharmaceuticals Inc's Cash from Investing Activities amounts to -42.8m USD.
What is Fusion Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-107%
-107%
The average annual Cash from Investing Activities growth rates for Fusion Pharmaceuticals Inc have been 41% over the past three years , -107% over the past five years .
You don't have any saved screeners yet
